Watch BKYI. Know when insiders buy.
One email the day a filing lands. Free.
BKYI
BIO KEY INTERNATIONAL INC
2.67
−0.14 −4.98%
USD · close Sep 8
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3.8MP/E —DIV YIELD —FCF YIELD -108.55%REV TTM —NET INCOME −$6MNET CASH $1.2M52W 2.67 – 10.30SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$529K | −$577K | — | -0.56 | −$846K | $0 | −$846K | Aug 13 |
| Q1 2026 · Mar 31 | — | — | — | −$158K | −$205K | — | -0.20 | −$358K | $0 | −$358K | Aug 13 |
| Q4 2025 · Dec 31derived | — | — | — | −$4.2M | −$4.3M | — | -10.27 | −$1.8M | $5K | −$1.8M | Jun 12 |
| Q3 2025 · Sep 30 | — | — | — | −$892K | −$965K | — | -0.15 | −$1.1M | $1K | −$1.1M | Nov 14 |
| Q2 2025 · Jun 30 | — | — | — | −$1.1M | −$1.2M | — | -2.01 | −$880K | $1K | −$881K | Aug 13 |
| Q1 2025 · Mar 31 | — | — | — | −$641K | −$737K | — | -1.57 | −$835K | $5K | −$840K | Aug 13 |
| Q4 2024 · Dec 31derived | — | — | — | −$1.3M | −$1.4M | — | -19.19 | −$515K | −$10K | −$505K | Jun 12 |
| Q3 2024 · Sep 30 | — | — | — | −$580K | −$739K | — | -0.39 | −$1.3M | $21K | −$1.3M | Nov 14 |
| Q2 2024 · Jun 30 | — | — | — | −$1.7M | −$1.7M | — | -1.00 | −$1.4M | $0 | −$1.4M | Nov 14 |
| Q1 2024 · Mar 31 | — | — | — | −$509K | −$510K | — | -0.32 | $297K | $2K | $295K | Nov 14 |
| Q4 2023 · Dec 31derived | — | — | — | −$2.7M | −$2.4M | — | -4.42 | −$1.5M | $1K | −$1.5M | Apr 23 |
| Q3 2023 · Sep 30 | — | — | — | −$2M | −$1.8M | — | -3.22 | −$167K | $0 | −$167K | Apr 23 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$6.8M | −$7.2M | — | -10.77 | −$4.7M | $12K | −$4.7M | — | — |
| FY2024 · to Dec 31 | — | — | −$4M | −$4.3M | — | -20.88 | −$2.9M | $13K | −$2.9M | — | — |
| FY2023 · to Dec 31 | — | — | −$8.8M | −$8.5M | — | -15.21 | −$3.8M | $1K | −$3.8M | — | — |
| FY2022 · to Dec 31 | — | — | −$9.9M | −$11.9M | — | -27.26 | −$6.2M | $82K | −$6.3M | — | — |
| FY2021 · to Dec 31 | — | — | −$4.9M | −$5.1M | — | -0.65 | −$9M | $42K | −$9M | — | — |
| FY2020 · to Dec 31 | — | — | −$5.2M | −$9.7M | — | -2.08 | −$5M | $36K | −$5M | — | — |
Every number comes from BIO KEY INTERNATIONAL INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.